ACEREVERS 1: Development of an Artificial Prototype Biosensor System for Identification and Treatment of Diabetic Ketoacidosis (DKA)
ISEF · 2022 Biomedical Engineering
Overview
Type-1 Diabetes (T1D) affects around 1.6 million (CDC). Diabetic Ketoacidosis (DKA) accounts for almost 56-74% of T1D-induced mortality. During the past decade, DKA-admission rates have increased exponentially with a third of hospitalizations resulting in multiple readmissions within the year of initial treatment. Statistics indicate many of these visits are unplanned, emergent, and critically severe. The DKA Prototype Project : ACEREVERS-1 (a latin for “acid turning”) is designed to provide immediate, responsive treatment to ketoacidotic effects caused by cellular inability to ingest glucose by utilizing electronics-based bioengineering and chemical techniques. The project created a prototype consisting of a Ketoacidotic receptor able to conduct a current in an acidic solution simulating the blood conditions during DKA. The prototype's ability to run the circuit during such a condition by activating a peristaltic pump that transfers an electrolytic solution consisting of NaHCO3 and insulin into the system containing one of a major ketone bodies, 3-hydroxybutryate, mixed with acetic-acid. By adjusting the potentiometers to specific resistances that allow ACEREVERS-1 to recognize and inhibit the circuit at neutral pH of 7.0-7.4, the pump can transfer the bicarbonate/insulin until the acidic effects are neutralized. Futuristic improvement checkpoints include adding a heat-resistant casing, cooling measures to offset overheating of the MOSFET, minimizing the circuit and sensor into a series of non-invasive microarrays simulating other pancreatic functions such as infusion of glucagon and/or somatostatin based on the blood conditions needing only a few microliter blood to diagnose and prevent DKA induced fatality or severe hypoglycemia.
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2023
Sugar High!: Integrating Glucose and Ketone Testing to Improve Prevention of Diabetic Ketoacidosis
ISEF · 2022
Sweet! - Integrating Glucose and Ketone Testing To Improve Efficiency in the Treatment of Diabetes
ISEF · 2026
The Infusion Solution: Designing a Multifunction Medical Pump to Treat Hyper/Hypoglycemia
ISEF · 2023
DiaVest II: A Non-Invasive Glucose Monitoring System for Diabetes Management
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair